Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis.

Source:http://linkedlifedata.com/resource/pubmed/id/15744001

Download in:

View as

General Info

PMID
15744001